Total Payments
$493,843
2024 Payments
$83,529
Companies
37
Transactions
1,579
Medicare Patients
4,504
Medicare Billing
$816,079
Payment Breakdown by Category
Other$381,821 (77.3%)
Consulting$49,594 (10.0%)
Food & Beverage$31,005 (6.3%)
Travel$31,003 (6.3%)
Education$419.38 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $372,536 | 171 | 75.4% |
| Consulting Fee | $49,594 | 22 | 10.0% |
| Food and Beverage | $31,005 | 1,197 | 6.3% |
| Travel and Lodging | $31,003 | 167 | 6.3% |
| Honoraria | $9,285 | 6 | 1.9% |
| Education | $419.38 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $219,874 | 430 | $0 (2024) |
| GENZYME CORPORATION | $59,210 | 107 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $48,387 | 131 | $0 (2024) |
| Genentech USA, Inc. | $46,146 | 105 | $0 (2024) |
| GlaxoSmithKline, LLC. | $41,427 | 273 | $0 (2024) |
| CSL Behring | $20,244 | 101 | $0 (2024) |
| Amgen Inc. | $16,760 | 27 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $15,027 | 23 | $0 (2017) |
| Mylan Specialty L.P. | $9,863 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,429 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83,529 | 249 | AstraZeneca Pharmaceuticals LP ($50,154) |
| 2023 | $69,199 | 259 | AstraZeneca Pharmaceuticals LP ($21,268) |
| 2022 | $82,500 | 225 | AstraZeneca Pharmaceuticals LP ($48,540) |
| 2021 | $36,384 | 180 | GlaxoSmithKline, LLC. ($12,917) |
| 2020 | $29,714 | 129 | AstraZeneca Pharmaceuticals LP ($13,397) |
| 2019 | $78,802 | 202 | AstraZeneca Pharmaceuticals LP ($36,547) |
| 2018 | $63,795 | 191 | AstraZeneca Pharmaceuticals LP ($36,656) |
| 2017 | $49,918 | 144 | Genentech USA, Inc. ($17,817) |
All Payment Transactions
1,579 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $555.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $282.74 | General |
| Category: Immunology | ||||||
| 12/12/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $161.70 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,145.00 | General |
| Category: Immunology | ||||||
| 12/02/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,597.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $101.54 | General |
| Category: Immunology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $224.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,170 | 16,045 | $1.3M | $381,895 |
| 2022 | 18 | 1,146 | 10,963 | $762,102 | $242,599 |
| 2021 | 12 | 1,159 | 7,334 | $184,153 | $101,015 |
| 2020 | 14 | 1,029 | 7,560 | $173,776 | $90,570 |
Total Patients
4,504
Total Services
41,902
Medicare Billing
$816,079
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 14 | 8,370 | $962,550 | $253,233 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 375 | 544 | $43,520 | $29,090 | 66.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 44 | 568 | $136,804 | $27,324 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 206 | $24,720 | $17,048 | 69.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 75 | 4,411 | $30,877 | $12,288 | 39.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 31 | 267 | $23,408 | $9,066 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $14,000 | $8,689 | 62.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 21 | 791 | $9,888 | $6,765 | 68.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 25 | 143 | $14,626 | $4,793 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $6,000 | $3,513 | 58.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 29 | 118 | $8,541 | $3,305 | 38.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 183 | 187 | $14,960 | $3,071 | 20.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 15 | 223 | $5,352 | $1,536 | 28.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 61 | 61 | $7,930 | $1,533 | 19.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,050 | $505.08 | 48.1% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 11 | 11 | $341.00 | $134.80 | 39.5% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 13 | 4,905 | $554,265 | $146,535 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 385 | 576 | $46,080 | $30,897 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 151 | $18,120 | $12,607 | 69.6% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 32 | 230 | $42,754 | $10,984 | 25.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 58 | 3,405 | $23,835 | $9,717 | 40.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 26 | 761 | $9,513 | $6,736 | 70.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $10,325 | $6,384 | 61.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 211 | 215 | $17,200 | $3,935 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $5,760 | $3,601 | 62.5% |
About Dr. Benjamin Close, M.D
Dr. Benjamin Close, M.D is a Internal Medicine healthcare provider based in Alexandria, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730185802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Close, M.D has received a total of $493,843 in payments from pharmaceutical and medical device companies, with $83,529 received in 2024. These payments were reported across 1,579 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($372,536).
As a Medicare-enrolled provider, Close has provided services to 4,504 Medicare beneficiaries, totaling 41,902 services with total Medicare billing of $816,079. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Specialist, Pediatric Allergy/Immunology
- Location Alexandria, LA
- Active Since 06/23/2005
- Last Updated 10/08/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730185802
Products in Payments
- FASENRA (Drug) $81,613
- TEZSPIRE (Biological) $81,512
- DUPIXENT (Biological) $79,879
- Xolair (Biological) $45,907
- AIRSUPRA (Drug) $32,470
- FASENRA (Biological) $29,043
- DUPIXENT (Drug) $19,742
- Hizentra (Biological) $19,679
- TRELEGY ELLIPTA (Drug) $18,955
- NIOX VERO DEVICE (Device) $15,013
- Dymista (Drug) $9,725
- SPIRIVA RESPIMAT (Drug) $6,375
- NUCALA (Biological) $5,502
- EUCRISA (Drug) $3,677
- Xhance (Drug) $1,471
- CUVITRU (Biological) $745.85
- SYMBICORT (Drug) $542.67
- PROAIR RESPICLICK (Drug) $500.00
- Haegarda (Biological) $437.03
- AREXVY (Drug) $425.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alexandria
Dr. Kanna Posina, M.d, M.D
Internal Medicine — Payments: $33,667
Internal Medicine $33,667
Robert Freedman, M.d, M.D
Internal Medicine — Payments: $18,837
Internal Medicine $18,837
Wayne Wu, M.d, M.D
Internal Medicine — Payments: $18,212
Internal Medicine $18,212
Michael Mitchell, M.d, M.D
Internal Medicine — Payments: $16,622
Internal Medicine $16,622
Scott Whittaker, M.d, M.D
Internal Medicine — Payments: $16,235
Internal Medicine $16,235
Dr. Laura Robinette, Md, MD
Internal Medicine — Payments: $15,826
Internal Medicine $15,826